BeOne Medicines (BEIGF) Net Income - Minority (2017 - 2020)
Historic Net Income - Minority for BeOne Medicines (BEIGF) over the last 4 years, with Q3 2020 value amounting to -$19.6 million.
- BeOne Medicines' Net Income - Minority fell 2436.7% to -$19.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$19.6 million, marking a year-over-year decrease of 2436.7%. This contributed to the annual value of -$16.2 million for FY2019, which is 1180.34% down from last year.
- Latest data reveals that BeOne Medicines reported Net Income - Minority of -$19.6 million as of Q3 2020, which was down 2436.7% from -$10.2 million recorded in Q2 2020.
- BeOne Medicines' Net Income - Minority's 5-year high stood at -$10.2 million during Q2 2020, with a 5-year trough of -$19.6 million in Q3 2020.
- In the last 4 years, BeOne Medicines' Net Income - Minority had a median value of -$14.6 million in 2018 and averaged -$15.0 million.
- Over the last 5 years, BeOne Medicines' Net Income - Minority had its largest YoY gain of 4137.0% in 2020, and its largest YoY loss of 2436.7% in 2020.
- Quarter analysis of 4 years shows BeOne Medicines' Net Income - Minority stood at -$14.4 million in 2017, then fell by 0.16% to -$14.4 million in 2018, then decreased by 11.8% to -$16.2 million in 2019, then dropped by 21.36% to -$19.6 million in 2020.
- Its last three reported values are -$19.6 million in Q3 2020, -$10.2 million for Q2 2020, and -$14.8 million during Q1 2020.